Marimed (MRMD) Free Cash Flow (2013 - 2026)
Marimed's (MRMD) quarterly Free Cash Flow came in at $930000.0 in Q1 2026, down 9.44% year-on-year from $1.0 million in Q1 2025, and down 52.48% on a QoQ basis from $2.0 million in Q4 2025.
Marimed (MRMD) Free Cash Flow (2013 - 2026) Analysis & Trends
Marimed (MRMD) has 14 years of Free Cash Flow data on file, last reported at $930000.0 in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 9.44% year-over-year to $930000.0 in Q1 2026; TTM through Mar 2026 was $3.0 million, a 183.52% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, up 198.34% from the prior year.
- Free Cash Flow for Q1 2026 stood at $930000.0, down from $2.0 million in the prior quarter.
- Over the last five years, Free Cash Flow for MRMD reached as high as $5.9 million in Q3 2023 and fell as low as -$7.7 million in Q2 2022.
- Historically, Free Cash Flow has averaged $222941.2 across 5 years, with a median of $930000.0 in 2026.
- Across the five-year window, Free Cash Flow plunged 223.6% in 2023 and surged 1688.0% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at $1.7 million in 2022, then plunged by 223.6% to -$2.1 million in 2023, then jumped by 31.49% to -$1.5 million in 2024, then surged by 233.04% to $2.0 million in 2025, then plunged by 52.48% to $930000.0 in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $930000.0 in Q1 2026, $2.0 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | 930,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 930,000.00 |
| Mar 31, 2026 | 930,000.00 |
| Dec 31, 2025 | 1.96 Mn |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | -1.30 Mn |
| Jun 30, 2025 | -1.30 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | -497,000.00 |
| Sep 30, 2024 | -497,000.00 |
| Jun 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Mar 31, 2024 | -158,000.00 |
| Mar 31, 2024 | -158,000.00 |
| Dec 31, 2023 | -2.15 Mn |
| Dec 31, 2023 | -2.15 Mn |